Epidemiology of Thygesons Superficial Punctate Keratitis
Researchers have studied the cause and effect of Thygeson’s Superficial Punctate Keratitis or Thygeson’s Superficial Punctate Keratopathy (TSPK) looking for patterns and commonalities that can help form useful conclusions. The epidemiology behind Thygeson’s SPK has experienced many blocks and detours while compiling statistics and analyzing information about this elusive disease.
Epidemiologists have collected detailed data about TSPK patients and codified all of the investigated facts in an attempt to compare victims, outbreak facts, severity of the symptoms, the effectiveness of various treatments, results of specific treatments, remission and recurrence data. The cause of Thygeson’s Superficial Punctate Keratitis remains unknown even though many unproven theories have gained traction over the decades since Phillips Thygeson first presented the disease to the medical profession in 1950 and it was subsequently named after him.
There are many unknown facts such as how many people experience TSPK in the United States or around the world. No country has documented the number of TSPK cases among their population. The consensus among the worldwide medical community is that TSPK does not cause death but that is in fact still not proven. There are conclusive studies that TSPK affects one race over another in any way. Researchers believe that TSPK has no preference to infect a body based on gender. So what is known?
Thygeson’s Superficial Punctate Keratitis has been reported in patients ranging in age from two and half years old to age seventy. The median average age of sufferers is 29 years old. This is why it is so important to check in with an eye doctor when symptoms of TSPK appear, especially if you note signs in a child or elderly individual who may not have the capacity to act in their own interest. The epidemiology of Thygeson’s Superficial Punctate Keratitis (TSPK) continues to monitor known cases of the disease, share information, and increase knowledge throughout the medical community around the world.
Required Link: http://emedicine.medscape.com/article/1197335-overview#a0199 http://www.crstoday.com/PDF%20Articles/0607/CRST0607_PR.pdf